TRNA METHYLASE AND TRNA PSEUDOURIDINE SYNTHASE
TRNA 甲基化酶和 TRNA 假尿苷合酶
基本信息
- 批准号:2415257
- 负责人:
- 金额:$ 17.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:RNA methylation S adenosylmethionine X ray crystallography chemical binding chemical kinetics cofactor conformation crystallization enzyme mechanism enzyme structure enzyme substrate enzyme substrate analog enzyme substrate complex halogenation methyltransferase mutant nuclear magnetic resonance spectroscopy nucleic acid structure nucleotide analog posttranscriptional RNA processing site directed mutagenesis stop flow technique transfer RNA transmethylation uracil nucleoside
项目摘要
The long term objective is to understand the mechanism of catalysis and
substrate recognition of tRNA (m5U54)-methyltransferase (RUMT). A
secondary objective is to initiate work on tRNA pseudo uridine synthase I
and II (II, psi55 and I, hisT).
The specific aims are summarized as follows: (1) We will study the
conformational changes that occur in tRNA and the T arm of tRNA on binding
to RUMT. Rapid kinetics will be probed using stopped flow fluorescence
quenching. Mutagenesis of the RNA substrate will be aimed at destabilizing
secondary and tertiary RNA structure, and the effect on catalysis by RUMT
will be destabilizing secondary and tertiary RNA structure, and the effect
on catalysis by RUMT will be assessed. In appropriate collaborations, NMR
and X-ray crystallography will be performed on the enzyme and substrate,
individually and in complex. (2) We will study aspects of tRNA
recognition by RUMT. RNA footprinting techniques will be used to identify
RUMT-RNA contacts outside of the T arm. Chemical synthesis of RNA analogs
will be used to obtain substrates with various functional group
substitutions, such as deoxyribose at specific positions. In vitro
selection (SELEX) will be used to identify "best binding' sequences. (3)
We will attempt to crystallize RUMT and RUMT-RNA complexes for future X-Ray
structure determination. (4). We will determine whether RNAs other than
tRNA are substrates for RUMT. (5) Studies will be performed with Pseudo
Uridine (psi55) Synthase II and Pseudo Uridine Synthase I (his T), closely
following the specific aims of our proposed studies of RUMT.
This work is significant at several different levels of biomedical
research. First, the research seeks to understand more about enzyme
catalysis, providing insight into how such reactions occur in the complex
environment of an RNA molecule. Second, the work attempts to identify
elements contributing to protein-RNA recognition and to uncover general
rules by which certain proteins recognize common structural features of
RNA. The work also seeks to identify conformational changes of tRNA which
accompany protein recognition, and to initiate structural studies on unique
RNA-protein complexes. Third, if other RNAs are potential substrates for
RUMT (or psi 55 synthase), the mutagenesis studies performed here will
assist in their identification. Finally, some effects of the anti-cancer
agent FUra may be due to its incorporation into RNA. As work in this area
progresses, this point will become clarified and could lead to the
identification and exploitation of new drug targets.
长期目标是了解催化和
tRNA(M5U54) - 甲基转移酶(RUMT)的底物识别。 一个
次要目标是启动对tRNA伪尿苷合酶I的工作
和II(II,PSI55和I,Hist)。
具体目的总结如下:(1)我们将研究
tRNA中发生的构象变化和结合tRNA的t臂
到Rumt。 快速动力学将使用停止流量荧光进行探测
淬火。 RNA底物的诱变将旨在破坏稳定
二级和第三级RNA结构,以及对Rumt催化的影响
将破坏次级和三级RNA结构的稳定,效果
关于Rumt的催化,将评估。 在适当的合作中,NMR
X射线晶体学将在酶和底物上进行,
单独和复杂。 (2)我们将研究tRNA的各个方面
Rumt的认可。 RNA足迹技术将用于识别
rumt-rna接触T臂外部。 RNA类似物的化学合成
将用于获得具有各种功能组的底物
取代,例如在特定位置的脱氧核糖。 体外
选择(SELEX)将用于识别“最佳绑定”序列。(3)
我们将尝试将Rumt和Rumt-RNA综合体结晶为未来的X射线
结构确定。 (4)。 我们将确定除了RNA以外的其他RNA是否
tRNA是Rumt的底物。 (5)将使用伪进行研究
尿苷(PSI55)合酶II和伪尿苷合酶I(他的T),紧密
遵循我们提议的Rumt研究的具体目的。
这项工作在几个不同水平的生物医学上都很重要
研究。 首先,研究试图更多地了解酶
催化,提供有关这种反应如何发生在复合物中的信息
RNA分子的环境。 其次,工作试图识别
有助于蛋白-RNA识别并发现一般的元素
某些蛋白质识别共同结构特征的规则
RNA。 这项工作还旨在确定tRNA的构象变化,
伴随蛋白质识别,并启动有关独特的结构研究
RNA蛋白质复合物。 第三,如果其他RNA是潜在的基板
RUMT(或PSI 55合酶),此处进行的诱变研究将
协助他们的身份证明。 最后,反癌的某些影响
Fura可能是由于其掺入RNA所致。 作为该领域的工作
进展,这一点将被澄清,并可能导致
识别和剥削新药物靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL V. SANTI其他文献
DANIEL V. SANTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL V. SANTI', 18)}}的其他基金
RELEASABLE LINKERS FOR POLYETHYLENE GLYCOL- AND DENDRIMER-DRUG CONJUGATES
聚乙二醇和树枝状聚合物药物缀合物的可释放连接体
- 批准号:
8363839 - 财政年份:2011
- 资助金额:
$ 17.73万 - 项目类别:
TRNA METHYLASE AND TRNA PSEUDOURIDINE SYNTHASE
TRNA 甲基化酶和 TRNA 假尿苷合酶
- 批准号:
2189613 - 财政年份:1996
- 资助金额:
$ 17.73万 - 项目类别:
TRNA METHYLASE AND TRNA PSEUDOURIDINE SYNTHASE
TRNA 甲基化酶和 TRNA 假尿苷合酶
- 批准号:
2701625 - 财政年份:1996
- 资助金额:
$ 17.73万 - 项目类别:
TRNA METHYLASE AND TRNA PSEUDOURIDINE SYNTHASE
TRNA 甲基化酶和 TRNA 假尿苷合酶
- 批准号:
2910150 - 财政年份:1996
- 资助金额:
$ 17.73万 - 项目类别:
ENZYME TARGETS OF OPPORTUNISTIC PATHOGENS IN AIDS
艾滋病中机会性病原体的酶靶标
- 批准号:
2067689 - 财政年份:1991
- 资助金额:
$ 17.73万 - 项目类别:
相似国自然基金
甘氨酸自由基酶YjjI在DNA修复中作用及其酶促反应机理研究
- 批准号:31570060
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
PhnJ催化的有机膦化合物中碳磷键断裂的酶反应机制研究
- 批准号:21342013
- 批准年份:2013
- 资助金额:10.0 万元
- 项目类别:专项基金项目
相似海外基金
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
基于机制的 SARS-CoV-2 RNA 加工机制靶向
- 批准号:
10671628 - 财政年份:2021
- 资助金额:
$ 17.73万 - 项目类别:
Mechanisms of Radical-Dependent Biological Methylation
自由基依赖性生物甲基化机制
- 批准号:
8321351 - 财政年份:2012
- 资助金额:
$ 17.73万 - 项目类别:
Mechanisms of Radical-Dependent Biological Methylation
自由基依赖性生物甲基化机制
- 批准号:
8841377 - 财政年份:2012
- 资助金额:
$ 17.73万 - 项目类别: